Status:
RECRUITING
Adenomyosis Patients With Infertility and Immunological Factors
Lead Sponsor:
Peking University Third Hospital
Conditions:
Adenomyosis
Eligibility:
FEMALE
18-40 years
Brief Summary
Infertile patients with adenomyosis who met the inclusion and exclusion criteria, after signing the informed consent form, the researchers recorded the clinical information of the patients and initiat...
Detailed Description
Adenomyosis is a common gynecological disease in women of reproductive age which is characterized by endometrial glands and stroma in the normal myometrium, accompanied by hypertrophy of the surroundi...
Eligibility Criteria
Inclusion
- Patients were diagnosed as adenomyosis by transvaginal ultrasound scans (The criteria for sonographic diagnosis of adenomyosis are with 2 or more of the following: heterogeneous myometrial texture with the presence of globular asymmetric uterus, thickening of the anterior and posterior myometrial wall, irregular cystic areas within the myometrium);
- 18≤ age ≤ 40 years old at first outpatient visit in our Reproductive Center;
- with regular menstrual cycle.
Exclusion
- Patients with intrauterine adhesion, uterine malformation, submucosal leiomyoma, or ≥ 5.0 cm in diameter leiomyoma;
- hydrosalpinx and systemic diseases;
- patients with other endocrine severe diseases, immune diseases, tumors and abnormal chromosomes in either partner.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06123975
Start Date
March 1 2024
End Date
October 1 2026
Last Update
April 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China